Meristem Family Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.28M | Buy |
17,564
+1,261
| +8% | +$84.7K | 0.14% | 87 |
|
|
2021
Q4 | $1.02M | Sell |
16,303
-2,283
| -12% | -$134K | 0.09% | 132 |
|
|
2021
Q3 | $1.1M | Buy |
18,586
+8,516
| +85% | +$561K | 0.11% | 114 |
|
|
2021
Q2 | $673K | Sell |
10,070
-292
| -3% | -$19K | 0.11% | 138 |
|
|
2021
Q1 | $654K | Sell |
10,362
-9,550
| -48% | -$594K | 0.13% | 105 |
|
|
2020
Q4 | $1.24M | Buy |
19,912
+8,600
| +76% | +$529K | 0.26% | 51 |
|
|
2020
Q3 | $682K | Buy |
11,312
+134
| +1% | +$8.06K | 0.17% | 73 |
|
|
2020
Q2 | $657K | Sell |
11,178
-2,935
| -21% | -$176K | 0.18% | 75 |
|
|
2020
Q1 | $787K | Buy |
14,113
+387
| +3% | +$23.7K | 0.24% | 60 |
|
|
2019
Q4 | $881K | Buy |
13,726
+829
| +6% | +$47.5K | 0.22% | 63 |
|
|
2019
Q3 | $654K | Sell |
12,897
-1,333
| -9% | -$62.6K | 0.18% | 82 |
|
|
2019
Q2 | $645K | Buy |
14,230
+1,638
| +13% | +$76.3K | 0.2% | 73 |
|
|
2019
Q1 | $601K | Buy |
12,592
+590
| +5% | +$29.4K | 0.2% | 66 |
|
|
2018
Q4 | $624K | Buy |
12,002
+55
| +0.5% | +$2.96K | 0.23% | 57 |
|
|
2018
Q3 | $742K | Hold |
11,947
| – | – | 0.25% | 54 |
|
|
2018
Q2 | $661K | Sell |
11,947
-1,742
| -13% | -$94.1K | 0.23% | 55 |
|
|
2018
Q1 | $866K | Sell |
13,689
-34
| -0.2% | -$2.19K | 0.31% | 47 |
|
|
2017
Q4 | $841K | Hold |
13,723
| – | – | 0.3% | 50 |
|
|
2017
Q3 | $875K | Hold |
13,723
| – | – | 0.35% | 44 |
|
|
2017
Q2 | $765K | Hold |
13,723
| – | – | 0.31% | 49 |
|
|
2017
Q1 | $746K | Sell |
13,723
-3,695
| -21% | -$203K | 0.3% | 48 |
|
|
2016
Q4 | $1.02M | Sell |
17,418
-2,870
| -14% | -$157K | 0.42% | 35 |
|
|
2016
Q3 | $1.09M | Buy |
20,288
+7,950
| +64% | +$511K | 0.46% | 34 |
|
|
2016
Q2 | $907K | Hold |
12,338
| – | – | 0.4% | 35 |
|
|
2016
Q1 | $788K | Hold |
12,338
| – | – | 0.35% | 38 |
|
|
2015
Q4 | $849K | Sell |
12,338
-258
| -2% | -$17.1K | 0.33% | 41 |
|
|
2015
Q3 | $746K | Hold |
12,596
| – | – | 0.39% | 35 |
|
|
2015
Q2 | $838K | Hold |
12,596
| – | – | 0.37% | 41 |
|
|
2015
Q1 | $812K | Hold |
12,596
| – | – | 0.34% | 43 |
|
|
2014
Q4 | $744K | Hold |
12,596
| – | – | 0.27% | 51 |
|
|
2014
Q3 | $645K | Buy |
12,596
+643
| +5% | +$32.1K | 0.28% | 53 |
|
|
2014
Q2 | $580K | Hold |
11,953
| – | – | 0.24% | 59 |
|
|
2014
Q1 | $621K | Sell |
11,953
-420
| -3% | -$22.3K | 0.27% | 57 |
|
|
2013
Q4 | $658K | Buy |
12,373
+310
| +3% | +$15.8K | 0.27% | 59 |
|
|
2013
Q3 | $558K | Hold |
12,063
| – | – | 0.26% | 58 |
|
|
2013
Q2 | $539K | Buy |
+12,063
| New | +$524K | 0.25% | 58 |
|
Other funds holding BMY
Meristem Family Wealth's BMY Position: Q1 2022 in Review
Meristem Family Wealth increased its Bristol-Myers Squibb (BMY) stake by 7.7% in Q1 2022, buying an estimated $84.7K and bringing the position to 17,564 shares worth $1.28M. The position accounts for 0.14% of the portfolio, ranked #87.
Meristem Family Wealth first reported a position in BMY in Q2 2013 and has held it in 36 quarters since. 2,516 funds tracked by Wall St. Rank hold BMY as of Q1 2022.
- Meristem Family Wealth held 17,564 shares of Bristol-Myers Squibb worth $1.28M as of Q1 2022.
- Meristem Family Wealth bought 1,261 Bristol-Myers Squibb shares in Q1 2022, an estimated $84.7K.
- Bristol-Myers Squibb made up 0.14% of Meristem Family Wealth's portfolio in Q1 2022, its #87 holding.
- Meristem Family Wealth first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 36 quarters since.
- 2,516 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.
Based on Meristem Family Wealth's 13F filing for Q1 2022, filed 11 May 2022.